May take a while for us to be affected, if at all we are a part D drug - further down the list - they aim to go after the big discrepancies in cost.
A Sweeping Action
"While the initial MFN rule was limited to just Medicare Part B, the public medical insurance program that covers some prescription drugs, the new package will attempt to touch all parts of the government’s insurance programs, as well as the public markets. The White House officials said this is not the same rule as the one brought forth during Trump’s first term. “This suite of actions is broader than that.”
The officials did not specifically say how the proposal would impact Medicare Part D, which covers brand-name and generic prescription drugs.
No drug or class will be off limits, according to the officials. However, the plan will focus on drugs that have the widest pricing gap between the U.S. and other nations as well as those with the largest expenditures."
https://www.biospace.com/policy/white-house-unwraps-massive-drug-pricing-policy-touching-all-corners-of-pharma
(20min delay)